Brief: Eagle Pharmaceuticals Inc - Brian Cahill Resigned From His Position As CFO Effective Immediately
08/03/2024 22:13
March 8 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS INC - BRIAN CAHILL RESIGNED FROM HIS
POSITION AS CFO EFFECTIVE IMMEDIATELY
* EAGLE PHARMACEUTICALS INC - STEVEN RATOFF WAS APPOINTED
INTERIM
CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:n0001104659-24-032458
Further company coverage: EGRX.O
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq